Montelukast induced acute hepatocellular liver injury
Open Access
- 1 January 2009
- journal article
- case report
- Published by Medknow in Journal of Postgraduate Medicine
- Vol. 55 (2), 141-142
- https://doi.org/10.4103/0022-3859.52850
Abstract
A 46-year-old male with uncontrolled asthma on inhaled albuterol and formoterol with budesonide was commenced on montelukast. He developed abdominal pain and jaundice 48 days after initiating montelukast therapy. His liver tests showed an increase in serum total bilirubin, conjugated bilirubin, aspartate aminotranferase, alanine aminotranferase, and alkaline phosphatase. The patient was evaluated for possible non-drug related liver injury. Montelukast was discontinued suspecting montelukast induced hepatocellular liver injury. Liver tests began to improve and returned to normal 55 days after drug cessation. Causality of this adverse drug reaction by the Council for International Organizations of Medical Sciences or Roussel Uclaf Causality Assessment Method (CIOMS or RUCAM) and Naranjo's algorithm was 'probable'. Liver tests should be monitored in patients receiving montelukast and any early signs of liver injury should be investigated with a high index of suspicion for drug induced liver injury.Keywords
This publication has 9 references indexed in Scilit:
- Causality assessment in hepatotoxicity by drugs and dietary supplementsBritish Journal of Clinical Pharmacology, 2008
- Assessment of drug‐induced liver injury in clinical practiceFundamental & Clinical Pharmacology, 2008
- Acute liver failure: Summary of a workshopHepatology, 2007
- Fatal liver failure following food supplements during chronic treatment with montelukastDigestive and Liver Disease, 2007
- Churg–Strauss syndrome associated with leukotriene receptor antagonists (LTRA)Clinical Rheumatology, 2007
- Montelukast-Induced HepatitisAnnals of Internal Medicine, 2004
- A Case of Montelukast-Induced HepatotoxicityAmerican Journal of Gastroenterology, 2003
- Causality assessment of adverse reactions to drugs—I. A novel method based on the conclusions of international consensus meetings: Application to drug-induced liver injuriesJournal of Clinical Epidemiology, 1993
- A method for estimating the probability of adverse drug reactionsClinical Pharmacology & Therapeutics, 1981